Service advice and planning
39 results
Applied filters
Ex-vivo non-GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing ex-vivo non-genetically modified organism gene therapies.
Managing controlled drugs for dental teams
16 March 2026This article provides an overview of controlled drug (CD) management for dental teams
Marketed CAR-T therapy
13 February 2026This document outlines key areas where Chief Pharmacists should focus pharmaceutical expertise prior to an organisation implementing CAR-T therapy.
Managing out of specification ATMPs
11 February 2026This document clarifies the regulatory expectation regarding OOS ATMPs and advises hospitals on governance in the event of an OOS ATMP being offered for use.
Bank and agency staff and Patient Group Directions
5 May 2026The below summarises the advice on the use of PGDs by bank and agency staff working within organisations.
Validation master plans
18 November 2025A validation master plan summarises all planned validation activities in a medicines preparation or manufacturing unit.
Registration of Quality Controllers: Medical Gas Pipeline Systems
18 November 2025Quality controllers who test NHS medical gas pipelines must be suitably trained and experienced
Somatic cell therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing somatic cell therapy product.
Radiopharmaceuticals: advice for chief pharmacists
18 November 2025The safe use of radiopharmaceuticals falls within the remit of chief pharmacists.
Understanding essential documentation for clinical trials submissions
30 April 2026Sponsor responsibilities for writing and maintaining essential documents required for Clinical Trial Authorisation applications